 |
Novel infectious disease therapeutics are focused on at-risk populations now more than ever. Clinical trials are complex; clinical trials during a public health emergency are even moreso. A strategic and proactive plan that accounts for factors like population-inherent risks and standard of care is necessary to succeed. A good clinical trial design can save money and frustration. During the COVID-19 pandemic, trials that could be paused without causing harm to patients were halted as hospitals reallocated resources to respond to the pandemic. But immunocompromised patients are needed in studies, especially during such emergencies. In this playbook, you’ll gain insight into what goes into a good plan, including:
|
